GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » Stock Based Compensation

Sun Pharmaceuticals Industries (BOM:524715) Stock Based Compensation : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries Stock Based Compensation?

Sun Pharmaceuticals Industries's Stock Based Compensation for the three months ended in Dec. 2023 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.


Sun Pharmaceuticals Industries Stock Based Compensation Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Stock Based Compensation Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sun Pharmaceuticals Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sun Pharmaceuticals Industries Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


Sun Pharmaceuticals Industries Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharmaceuticals Industries (BOM:524715) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (BOM:524715) Headlines

No Headlines